| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.67B | 2.64B | 2.51B | 2.46B | 2.28B | 2.16B |
| Gross Profit | 1.88B | 1.84B | 1.76B | 1.64B | 1.59B | 1.58B |
| EBITDA | 874.80M | 1.93B | 1.62B | 1.75B | 1.52B | 1.72B |
| Net Income | 1.43B | 1.05B | 174.90M | 300.60M | 887.90M | -3.73B |
Balance Sheet | ||||||
| Total Assets | 36.28B | 36.35B | 35.67B | 37.01B | 36.64B | 38.06B |
| Cash, Cash Equivalents and Short-Term Investments | 318.40M | 380.60M | 296.40M | 679.00M | 978.70M | 2.60B |
| Total Debt | 16.36B | 16.77B | 15.71B | 15.87B | 15.47B | 16.42B |
| Total Liabilities | 17.69B | 18.17B | 17.65B | 18.29B | 17.46B | 19.07B |
| Stockholders Equity | 18.41B | 18.19B | 17.84B | 18.53B | 19.00B | 18.83B |
Cash Flow | ||||||
| Free Cash Flow | 849.90M | 659.40M | 624.10M | 1.09B | 844.40M | 645.50M |
| Operating Cash Flow | 1.02B | 1.07B | 1.07B | 1.12B | 868.20M | 666.90M |
| Investing Cash Flow | -402.20M | -460.00M | -438.90M | -481.30M | -342.00M | -356.60M |
| Financing Cash Flow | -572.70M | -526.20M | -1.01B | -941.30M | 55.30M | -201.90M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | AU$13.52B | 16.15 | 7.99% | 4.29% | 4.75% | 170.39% | |
70 Outperform | AU$21.52B | 15.03 | 7.71% | 4.13% | 5.44% | 231.88% | |
66 Neutral | AU$11.68B | 11.52 | 9.03% | 4.72% | 0.29% | 83.44% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
60 Neutral | $10.27B | 27.18 | 3.56% | 4.41% | 12.66% | ― | |
54 Neutral | AU$7.97B | 117.44 | 0.71% | 4.39% | -18.48% | ― |
Scentre Group has brought Australian Retirement Trust in as a new joint venture partner at Westfield Sydney, with the superannuation fund acquiring a 19.9% stake for $864 million, in line with the centre’s June 2025 book value at a 4.69% capitalisation rate. Scentre will retain an 80.1% interest and continue to manage property, leasing and development, reinforcing its control over one of Australia’s flagship CBD retail assets, which attracts more than 33 million customers annually and generated $1.1 billion in sales in 2024. The deal is part of Scentre’s broader capital recycling strategy, following the recent $1.3 billion joint venture at Westfield Chermside, and lifts announced third-party capital inflows in 2025 to about $2.2 billion. After investing $3.3 billion in the Westfield Sydney precinct over time, and selling its three office towers in 2019, Scentre has now realised roughly $2.4 billion from the asset, leaving a net investment of $0.9 billion against a remaining 80.1% stake valued at $3.5 billion, effectively quadrupling its capital since acquisition and underscoring its ability to unlock value for securityholders while maintaining operational control.
The most recent analyst rating on (AU:SCG) stock is a Buy with a A$4.60 price target. To see the full list of analyst forecasts on Scentre Group stock, see the AU:SCG Stock Forecast page.
Scentre Group has disclosed a change in the interests of its director, Elliott Rusanow, following the vesting of performance rights under the company’s Performance Rights Plan on 15 December 2025. Rusanow received 994,583 Scentre Group ordinary securities for nil consideration as 957,608 performance rights vested, increasing his directly held ordinary securities to 994,583 and leaving him with 3,164,812 remaining performance rights, while his indirect holding via Tellammy Pty Ltd remains at 2,016,843 ordinary securities. The transaction, a standard vesting event under the company’s long-term incentive framework, underscores the alignment of executive remuneration with shareholder interests, without involving any on-market trading or cash consideration.
The most recent analyst rating on (AU:SCG) stock is a Buy with a A$4.55 price target. To see the full list of analyst forecasts on Scentre Group stock, see the AU:SCG Stock Forecast page.
Scentre Group has notified the market of the issue of 5,813,470 fully paid stapled securities, following the exercise or conversion of previously unquoted options or other unquoted convertible securities. The new stapled securities, issued on 15 December 2025, increase the company’s equity base and marginally dilute existing holders, reflecting the ongoing operation of its incentive or financing structures and underscoring continued engagement by participants in its equity-linked schemes.
The most recent analyst rating on (AU:SCG) stock is a Buy with a A$4.55 price target. To see the full list of analyst forecasts on Scentre Group stock, see the AU:SCG Stock Forecast page.
Scentre Group has announced a new joint venture with a Dexus managed fund, selling a 25% interest in Westfield Chermside, Brisbane for $683 million. This transaction aligns with Scentre Group’s long-term capital management strategy, introducing approximately $1.3 billion of new capital to support its strategic objectives and sustainable growth.
The most recent analyst rating on (AU:SCG) stock is a Buy with a A$4.60 price target. To see the full list of analyst forecasts on Scentre Group stock, see the AU:SCG Stock Forecast page.
Scentre Group has acknowledged a media report regarding potential transactions involving an interest in Westfield Sydney. As part of its capital management strategy, the company is in discussions with third parties about joint venture opportunities, which may or may not lead to new transactions. Any developments will be disclosed in line with continuous disclosure obligations.
The most recent analyst rating on (AU:SCG) stock is a Buy with a A$4.60 price target. To see the full list of analyst forecasts on Scentre Group stock, see the AU:SCG Stock Forecast page.
Scentre Group has announced the issuance of 107,548 performance rights as part of an employee incentive scheme. These securities are unquoted and are not intended to be listed on the ASX, reflecting the company’s strategy to incentivize and retain talent, which could strengthen its operational capabilities and market position.
The most recent analyst rating on (AU:SCG) stock is a Buy with a A$4.60 price target. To see the full list of analyst forecasts on Scentre Group stock, see the AU:SCG Stock Forecast page.
Scentre Group reported a 3.1% increase in customer visitation to its Westfield destinations, with total business partner sales rising to $29.5 billion, reflecting strong demand and high occupancy rates. The company continues to invest in redevelopments and new experiences, enhancing its market position and driving growth, as evidenced by recent openings and capital management strategies.
The most recent analyst rating on (AU:SCG) stock is a Buy with a A$4.50 price target. To see the full list of analyst forecasts on Scentre Group stock, see the AU:SCG Stock Forecast page.
Scentre Group has acknowledged a media report about a potential sale of a further interest in Westfield Chermside to a Dexus fund, as part of its ongoing capital management strategy. The company is exploring strategic opportunities, including forming joint ventures, and will keep the market informed of any new transactions, highlighting its commitment to transparency and strategic growth.
The most recent analyst rating on (AU:SCG) stock is a Hold with a A$4.00 price target. To see the full list of analyst forecasts on Scentre Group stock, see the AU:SCG Stock Forecast page.
Scentre Group has successfully priced €500 million of 8-year senior notes under its Euro Medium Term Note Programme, with a fixed coupon of 3.45%. The proceeds will be used to repay existing debts, aligning with the Group’s strategy to diversify funding sources, extend debt maturity, and reduce the overall cost of capital. This marks the Group’s return to the EUR market, potentially strengthening its financial positioning and operational flexibility.
The most recent analyst rating on (AU:SCG) stock is a Buy with a A$4.60 price target. To see the full list of analyst forecasts on Scentre Group stock, see the AU:SCG Stock Forecast page.
Scentre Group has announced the appointment of Julie Ann Coates as a director, effective from October 1, 2025. The notice reveals that Coates currently holds no securities or interests in the company’s trusts or contracts, indicating a fresh start in her role. This appointment could signal strategic shifts or reinforce governance within Scentre Group, potentially impacting its operational strategies and stakeholder relations.
The most recent analyst rating on (AU:SCG) stock is a Buy with a A$4.60 price target. To see the full list of analyst forecasts on Scentre Group stock, see the AU:SCG Stock Forecast page.